Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease
Sponsor: Norwegian University of Science and Technology
Summary
To study the association between DISC1 RNA expression levels and cardiac function in patients with schizophrenia.
Official title: The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease - The Link Between DISC1 and Cardiac Function in Patients With Schizophrenia
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
OBSERVATIONAL
Enrollment
120
Start Date
2023-12-13
Completion Date
2038-06
Last Updated
2025-06-22
Healthy Volunteers
No
Interventions
Echocardiography
ultrasound assessment of heart structure, volume and function
Cardiac Magnetic Resonance Imaging
MRI assessment of heart structure, volume, function and tissue characteristics
Electrocardiography
Assessment of cardiac rhythm and electrical activity
Blood sampling
To measure DISC1 mRNA expression and other potential biomarkers
Locations (2)
Norwegian University of Science and Technology
Trondheim, Norway
St Olavs Hospital, Trondheim University Hospital
Trondheim, Norway